Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Smart Diaper Could Provide Quick and Painless Bedside Urinalysis

By LabMedica International staff writers
Posted on 06 May 2022

The concentration of certain compounds in urine can provide information about many different conditions, including kidney disease, urinary tract infections and electrolyte deficiencies. More...

Though many people with diabetes monitor their glucose levels with blood tests, glucose levels in their urine can also reveal spikes or dips. To analyze urine, however, physicians typically must order a urinalysis from a hospital lab, which takes time, or use paper test strips, which aren’t very sensitive. Neither system can deliver fast, bedside analyses. Now, researchers have designed a flexible sensor that fits in a diaper, measures multiple components in urine and can share those results over Bluetooth to provide real-time bedside analyses for incontinent, elderly or infant patients.

Urine can reveal a lot about a person’s health. But physicians don’t currently have a convenient or fast way of tracking the concentration of important compounds in their patients’ urine. Some researchers have explored wearable devices to monitor health markers—like electrolyte and sugar content in sweat. Researchers at the Sun Yat-Sen University (Guangzhou, China) wanted to design a similar type of wearable device that could accurately and sensitively measure the concentration of multiple health markers in urine and give real-time feedback to care providers.

The team first fabricated a flexible electrode array about the size of a U.S. quarter. They included five different electrodes on the array that were designed to specifically detect potassium ions, sodium ions, hydrogen peroxide, uric acid or glucose, which are biomarkers for various conditions. Then they connected the array to a circuit board that had a Bluetooth module and lithium-ion battery power source. When the array was exposed to urine samples from three volunteers, it performed as well as a commercial urine test system.

Next, the researchers incorporated the array into a diaper and found that, when urine was present, they could get readable signals for the biomarkers. However, they anticipate that in a real-world setting, where dry diapers become slowly saturated with urine, the electrode array would have to take multiple measurements to get stable readings. So, with optimization, this “smart” diaper could be a way to provide quick and painless urinalysis with wearable device technology, according to the researchers.

Related Links:
Sun Yat-Sen University 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: These images show breast tumors in a new preclinical model developed by Garvan researchers. The cells carry a fluorescent sensor that lights up blue/green when CDK1—the protein \'engine\' cells need to divide—is switched on. Using it, the team watched CDK1 activity rise as tumors became invasive and stay high in tumors that kept growing despite treatment. (Image Credit: Dr. Max Nobis / Garvan Institute)

Study Finds Potential Marker of Targeted Drug Resistance in Breast Cancer

Estrogen receptor-positive breast cancer is the most common breast cancer subtype and is driven by estrogen. Many patients are treated with CDK4/6 inhibitors alongside hormone therapy, but these drugs... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image: Four-quadrant streaking of fecal samples on chromogenic UTI agar shows various patterns of relative bacterial species abundance. The assorted shapes of the pinkish colonies indicate different E. coli strains. (Photo courtesy of Sokurenko Lab)

Stool Testing Predicts UTI Risk and Guides Antibiotic Selection

Urinary tract infections (UTIs) are a common reason for antibiotic prescribing in general medical practice and can be painful in postmenopausal women, sometimes progressing to kidney infection or life-threatening... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The ExaccType ESR1 dPCR Kit uses digital PCR technology to detect key ESR1 mutations associated with acquired resistance to endocrine therapy. (Photo courtesy of  BIOTYPE)

Collaboration Expands Access to Tests for Cancer Treatment Resistance and Toxicity Risk

Precision medicine in oncology relies on molecular testing to identify biomarkers that can help guide treatment decisions. In hormone receptor-positive, HER2-negative metastatic breast cancer, ESR1 mutations... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.